Page 108 - Read Online

Page 14 of 14 Anand et al. J Cancer Metastasis Treat 2019;5:6 I http://dx.doi.org/10.20517/2394-4722.2018.98

13. Ortel B, Shea CR, Calzavara-Pinton P. Molecular mechanisms of photodynamic therapy. Front Biosci (Landmark Ed) 2009;14:4157-72.
14. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, et al. Guidelines on the use of photodynamic therapy for
nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad
Dermatol 2007;56:125-43.
15. Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM. Influence of 5-aminolevulinic acid and red light on collagen metabolism
of human dermal fibroblasts. J Invest Dermatol 2003;120:325-31.
16. Campbell SM, Tyrrell J, Marshall R, Curnow A. Effect of MAL-photodynamic therapy on hypertrophic scarring. Photodiagnosis Photodyn
Ther 2010;7:183-8.
17. Cuenca RE, Allison RR, Sibata C, Downie GH. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg
Oncol 2004;11:322-7.
18. Allison RR, Sibata C, Mang TS, Bagnato VS, Downie GH, et al. Photodynamic therapy for chest wall recurrence from breast cancer.
Photodiagnosis Photodyn Ther 2004;1:157-71.
19. Liu Y, Hou G, Zhang X, Liu JJ, Zhang S, et al. A pilot randomized clinical study of the additive treatment effect of photodynamic therapy in
breast cancer patients with chest wall recurrence. J Breast Cancer 2014;17:161-6.
20. Maytin EV, Anand S, Riha M, Lohser S, Tellez A, et al. 5-Fluorouracil enhances protoporphyrin IX accumulation and lesion clearance
during photodynamic therapy of actinic keratoses: a mechanism-based clinical trial. Clin Cancer Res 2018;24:3026-35.
21. Sinha AK, Anand S, Ortel BJ, Chang Y, Mai Z, et al. Methotrexate used in combination with aminolaevulinic acid for photodynamic killing
of prostate cancer cells. Br J Cancer 2006;95:485-95.
22. Anand S, Honari G, Hasan T, Elson P, Maytin EV. Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin
carcinoma cells in vitro and in vivo. Clin Cancer Res 2009;15:3333-43.
23. Anand S, Wilson C, Hasan T, Maytin EV. Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based
photodynamic therapy. Cancer Res 2011;71:6040-50.
24. Anand S, Rollakanti KR, Brankov N, Brash DE, Hasan T, et al. Fluorouracil enhances photodynamic therapy of squamous cell carcinoma
via a p53-independent mechanism that increases protoporphyrin IX levels and tumor cell death. Mol Cancer Ther 2017;16:1092-101.
25. Rollakanti KR, Anand S, Maytin EV. Vitamin D enhances the efficacy of photodynamic therapy in a murine model of breast cancer. Cancer
Med 2015;4:633-42.
26. Anand S, Hasan T, Maytin EV. Mechanism of differentiation-enhanced photodynamic therapy for cancer: upregulation of
coproporphyrinogen oxidase by C/EBP transcription factors. Mol Cancer Ther 2013;12:1638-50.
27. Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates
5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 1998;34:1274-81.
28. Yasuno H, Kurasawa M, Yanagisawa M, Sato Y, Harada N, et al. Predictive markers of capecitabine sensitivity identified from the
expression profile of pyrimidine nucleoside-metabolizing enzymes. Oncol Rep 2013;29:451-8.
29. Walko CM, Lindley C. Capecitabine: a review. Clin Ther 2005;27:23-44.
30. Venturini M. Rational development of capecitabine. Eur J Cancer 2002;38:3-9.
31. Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 2008;8:228.
32. Duan X, Chan C, Guo N, Han W, Weichselbaum RR, et al. Photodynamic therapy mediated by nontoxic core-shell nanoparticles synergizes with
immune checkpoint blockade to elicit antitumor immunity and antimetastatic effect on breast cancer. J Am Chem Soc 2016;138:16686-95.
33. Kolinsky K, Zhang YE, Dugan U, Heimbrook D, Packman K, et al. Novel regimens of capecitabine alone and combined with irinotecan and
bevacizumab in colorectal cancer xenografts. Anticancer Res 2009;29:91-8.
34. Toi M, Masuda N, Lee SJ. Capecitabine for primary breast cancer. Oncotarget 2017;8:110739-40.
35. Toi M, Masuda N, Ohashi Y. Adjuvant capecitabine for breast cancer. N Engl J Med 2017;377:791-2.
36. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008;22:659-61.
37. Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 2016;7:27-31.
38. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003;3:330-8.
39. Anand S, Rollakanti KR, Horst RL, Hasan T, Maytin EV. Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell
death in a murine model of cutaneous squamous cell carcinoma. Photochem Photobiol 2014;90:1126-35.
40. Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol 2001; doi: 10.1002/0471142735.im2002s39.
41. Paschall AV, Liu K. An orthotopic mouse model of spontaneous breast cancer metastasis. J Vis Exp 2016; doi: 10.3791/54040.
42. Longo JP, Muehlmann LA, Miranda-Vilela AL, Portilho FA, de Souza LR, et al. Prevention of distant lung metastasis after photodynamic
therapy application in a breast cancer tumor model. J Biomed Nanotechnol 2016;12:689-99.
43. Kim JB, Urban K, Cochran E, Lee S, Ang A, et al. Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS
One 2010;5:e9364.